DK1789395T3 - Fremgangsmåde til chiral inversion af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og optisk berigede blandinger deraf - Google Patents
Fremgangsmåde til chiral inversion af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og optisk berigede blandinger derafInfo
- Publication number
- DK1789395T3 DK1789395T3 DK05759707T DK05759707T DK1789395T3 DK 1789395 T3 DK1789395 T3 DK 1789395T3 DK 05759707 T DK05759707 T DK 05759707T DK 05759707 T DK05759707 T DK 05759707T DK 1789395 T3 DK1789395 T3 DK 1789395T3
- Authority
- DK
- Denmark
- Prior art keywords
- dibenz
- azepine
- carboxamide
- dihydro
- hydroxy
- Prior art date
Links
- BMPDWHIDQYTSHX-CQSZACIVSA-N (R)-MHD Chemical compound C1[C@@H](O)C2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 BMPDWHIDQYTSHX-CQSZACIVSA-N 0.000 title 1
- BMPDWHIDQYTSHX-AWEZNQCLSA-N (S)-MHD Chemical compound C1[C@H](O)C2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 BMPDWHIDQYTSHX-AWEZNQCLSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0415664A GB2416167A (en) | 2004-07-13 | 2004-07-13 | Chiral inversion and esterification of (S)- and (R)-10-hydroxy-dibenzazepine carboxamides |
| PCT/GB2005/002744 WO2006005951A1 (fr) | 2004-07-13 | 2005-07-13 | Procede d'inversion chirale de (s)-(+)- et (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide et melanges optiquement enrichis de ceux-ci |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1789395T3 true DK1789395T3 (da) | 2009-04-20 |
Family
ID=32893499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05759707T DK1789395T3 (da) | 2004-07-13 | 2005-07-13 | Fremgangsmåde til chiral inversion af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og optisk berigede blandinger deraf |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7999100B2 (fr) |
| EP (1) | EP1789395B8 (fr) |
| JP (1) | JP2008506676A (fr) |
| CN (1) | CN100582095C (fr) |
| AR (1) | AR050170A1 (fr) |
| AT (1) | ATE420864T1 (fr) |
| AU (1) | AU2005261497A1 (fr) |
| BR (1) | BRPI0513383A (fr) |
| CA (1) | CA2574002C (fr) |
| DE (1) | DE602005012405D1 (fr) |
| DK (1) | DK1789395T3 (fr) |
| ES (1) | ES2320155T3 (fr) |
| GB (1) | GB2416167A (fr) |
| HR (1) | HRP20090212T1 (fr) |
| MX (1) | MX2007000575A (fr) |
| PL (1) | PL1789395T3 (fr) |
| PT (1) | PT103308B (fr) |
| RU (1) | RU2382772C2 (fr) |
| SI (1) | SI1789395T1 (fr) |
| WO (1) | WO2006005951A1 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0515690D0 (en) | 2005-07-29 | 2005-09-07 | Portela & Ca Sa | Asymmetric catalytic reduction |
| GB2437078A (en) * | 2006-04-11 | 2007-10-17 | Portela & Ca Sa | 10-Acyloxy-5H-dibenzo[b,f]azepine-5-carboxamides & their asymmetric hydrogenation to the chiral 10,11-dihydro derivatives |
| GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
| US8372431B2 (en) | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
| US20120022047A1 (en) * | 2009-04-02 | 2012-01-26 | Glenmark Generics Ltd | Process for the purification of eslicarbazepine acetate |
| EP2459198A1 (fr) | 2009-07-27 | 2012-06-06 | Bial-Portela & CA, S.A. | Utilisation de dérivés de 5h-dibenz / b, f/ azépine-5-carboxamide pour le traitement de la fibromyalgie |
| WO2011045648A2 (fr) * | 2009-10-12 | 2011-04-21 | Matrix Laboratories Limited | Procédé de préparation de (s)-(-)-10-acétoxy-10,11-dihydro-5h-dibenz[b,f]azépine-5-carboxamide et ses esters |
| WO2011091131A2 (fr) * | 2010-01-23 | 2011-07-28 | Dr. Reddy's Laboratories Ltd. | Acétate d'eslicarbazépine et ses polymorphes |
| WO2011117885A1 (fr) * | 2010-03-23 | 2011-09-29 | Intas Pharmaceuticals Limited | Procédé de préparation d'énantiomères de licarbazépine |
| EP2683691B1 (fr) | 2011-03-08 | 2018-06-06 | Jubilant Life Sciences Limited | PROCÉDÉ DE PRÉPARATION DU (S)-(+)-10,11-DIHYDRO-10-HYDROXY-5H-DIBENZ[b,f]AZÉPINE-5-CARBOXAMIDE ET DE SES ESTERS PAR RÉDUCTION ÉNANTIOSÉLECTIVE DU 10,11-DIHYDRO-10-OXO-5H-DIBENZ[b,f]AZÉPINE-5-CARBOXAMIDE |
| WO2012156987A2 (fr) * | 2011-05-19 | 2012-11-22 | Glenmark Generics Limited | Nouveau procédé de préparation d'eslicarbazépine |
| US20150065704A1 (en) | 2011-07-13 | 2015-03-05 | Ketan Hirpara | Process for the preparation and purification of eslicarbazepine acetate and intermediates thereof |
| IN2015DN02296A (fr) | 2012-09-26 | 2015-08-21 | Ranbaxy Lab Ltd | |
| EP3064490A1 (fr) | 2015-03-06 | 2016-09-07 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Procédé amélioré pour la préparation d'eslicarbazépine et d'acétate d'eslicarbazépine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT101732B (pt) * | 1995-06-30 | 1997-12-31 | Portela & Ca Sa | Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso |
| PT101876B (pt) * | 1996-05-27 | 1999-09-30 | Portela & Ca Sa | Novos derivados de 10,11-di-hidro-10-oxo-5h-dibenzo(b,f)azepina-5-carboxamida |
| GB0111566D0 (en) * | 2001-05-11 | 2001-07-04 | Portela & Ca Sa | Method for preparation of (s)-(+)-and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azephine-5-carboxamide |
-
2004
- 2004-07-13 GB GB0415664A patent/GB2416167A/en not_active Withdrawn
-
2005
- 2005-07-13 RU RU2007105228/04A patent/RU2382772C2/ru not_active IP Right Cessation
- 2005-07-13 DE DE602005012405T patent/DE602005012405D1/de not_active Expired - Lifetime
- 2005-07-13 DK DK05759707T patent/DK1789395T3/da active
- 2005-07-13 ES ES05759707T patent/ES2320155T3/es not_active Expired - Lifetime
- 2005-07-13 BR BRPI0513383-1A patent/BRPI0513383A/pt not_active IP Right Cessation
- 2005-07-13 AT AT05759707T patent/ATE420864T1/de active
- 2005-07-13 AU AU2005261497A patent/AU2005261497A1/en not_active Abandoned
- 2005-07-13 MX MX2007000575A patent/MX2007000575A/es active IP Right Grant
- 2005-07-13 AR ARP050102910A patent/AR050170A1/es unknown
- 2005-07-13 CN CN200580030684A patent/CN100582095C/zh not_active Expired - Fee Related
- 2005-07-13 EP EP05759707A patent/EP1789395B8/fr not_active Expired - Lifetime
- 2005-07-13 CA CA2574002A patent/CA2574002C/fr not_active Expired - Lifetime
- 2005-07-13 US US11/572,077 patent/US7999100B2/en active Active
- 2005-07-13 HR HR20090212T patent/HRP20090212T1/hr unknown
- 2005-07-13 WO PCT/GB2005/002744 patent/WO2006005951A1/fr not_active Ceased
- 2005-07-13 JP JP2007520888A patent/JP2008506676A/ja active Pending
- 2005-07-13 SI SI200530622T patent/SI1789395T1/sl unknown
- 2005-07-13 PT PT103308A patent/PT103308B/pt not_active IP Right Cessation
- 2005-07-13 PL PL05759707T patent/PL1789395T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0513383A (pt) | 2008-05-06 |
| CA2574002C (fr) | 2014-02-04 |
| CN100582095C (zh) | 2010-01-20 |
| PT103308B (pt) | 2008-06-11 |
| GB0415664D0 (en) | 2004-08-18 |
| AU2005261497A1 (en) | 2006-01-19 |
| AR050170A1 (es) | 2006-10-04 |
| ATE420864T1 (de) | 2009-01-15 |
| RU2382772C2 (ru) | 2010-02-27 |
| WO2006005951A1 (fr) | 2006-01-19 |
| SI1789395T1 (sl) | 2009-06-30 |
| CA2574002A1 (fr) | 2006-01-19 |
| PL1789395T3 (pl) | 2009-06-30 |
| ES2320155T3 (es) | 2009-05-19 |
| PT103308A (pt) | 2007-01-31 |
| MX2007000575A (es) | 2007-03-30 |
| EP1789395B8 (fr) | 2009-08-12 |
| CN101023061A (zh) | 2007-08-22 |
| DE602005012405D1 (de) | 2009-03-05 |
| US7999100B2 (en) | 2011-08-16 |
| EP1789395B1 (fr) | 2009-01-14 |
| RU2007105228A (ru) | 2008-08-20 |
| EP1789395A1 (fr) | 2007-05-30 |
| US20080293934A1 (en) | 2008-11-27 |
| GB2416167A (en) | 2006-01-18 |
| HRP20090212T1 (hr) | 2009-09-30 |
| JP2008506676A (ja) | 2008-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1789395T3 (da) | Fremgangsmåde til chiral inversion af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og optisk berigede blandinger deraf | |
| DK1824475T3 (da) | Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol | |
| DK1667986T3 (da) | Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf | |
| DE602004008386D1 (de) | System und Methode zur Herstellung von Brillengläsern, Programm und Medium | |
| ATE452883T1 (de) | KRISTALLINE FORM VON 1-CHLOR-4-(ß-D-GLUCOPYRANOS- 1-YL)-2-Ä4-((S)-TETRAHYDROFURAN-3-YLOXY)- BENZYLÜBENZOL, VERFAHREN ZU DESSEN HERSTELLUNG UND DESSEN VERWENDUNG ZUR HERSTELLUNG VON MEDIKAMENTEN | |
| DK2308507T3 (da) | Fremgangsmåder til behandling af præeklampsi | |
| DE602005015473D1 (de) | Verfahren und mittel zur herstellung von hyaluronan | |
| DK1564202T3 (da) | Ny fremgangsmåde til fremsitlling af og en ny krystalform af agomelation samt farmaceutiske sammensætninger indeholdende denne | |
| DK1477480T3 (da) | Fremgangsmåde til racemisering af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og optisk berigede blandinger deraf | |
| ATE397933T1 (de) | Kristallinform gamma-d von ivabradine- hydrochlorid, verfahren zu dessen herstellung und diesen enthaltende pharmazeutische zusammensetzung | |
| EP1920244A4 (fr) | Spectromètre de masse à proportion d isotopes et procédés de détermination de proportions d isotopes | |
| DK1668125T3 (da) | Modificerede enzymer, fremgangsmåde til fremstilling af modificerede enzymer og anvendelser deraf | |
| DE502005008601D1 (de) | Optisches Bauteil aus Quarzglas, Verfahren zur Herstellung des Bauteils und Verwendung desselben | |
| FI20030771A7 (fi) | Menetelmä toksisten syanobakteerien määrittämiseksi | |
| DE502005003004D1 (de) | Verfahren zur herstellung von polycarbonat | |
| DK1759587T3 (da) | Fremgangsmåde til produktion af fermenteret mælk og fermenteret mælk | |
| DK1642897T3 (da) | Alfa-krystalform af strontiumranelat, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| DK1575941T3 (da) | Fremgangsmåde til fremstilling af (S)-pantoprazol | |
| DE602004031350D1 (de) | Penamkristall und verfahren zu dessen herstellung | |
| DE602005001383D1 (de) | Optisches Taktrückgewinnungs-Verfahren und zugehörige Vorrichtung | |
| DK1502590T3 (da) | Heterocykliske oximderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf ved behandling af diabetes type II | |
| DE602006018129D1 (de) | Codierer, decodierer und verfahren dafür | |
| ATE406372T1 (de) | Verfahren zur herstellung von 3-o-geschützten morphinonen und 3-o-geschützten morphinondienolcarboxylaten | |
| DK1745844T3 (da) | System og fremgangsmåde til bortskaffelse af urenheder | |
| DK1656365T3 (da) | Fremgangsmåde til fremstilling af enantiomerisk rent mirtazapin |